Three-dimensional telomeric analysis of isolated circulating tumor cells (CTCs) defines CTC subpopulations

Translational Oncology

Volumn 6, Issue 1, 2013, Pages 51-65

  Awe, Julius Adebayo ^a,b,c   Xu, Mark Chu ^a   Wechsler, Janine ^d,e   Benali Furet, Naoual ^d   Cayre, Yvon E ^d,f   Saranchuk, Jeff ^g   Drachenberg, Darrel ^g   Mai, Sabine ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF SKÖVDE   (Sweden)

^d ScreenCell   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CELL STRUCTURE; CHROMOSOMAL INSTABILITY; CIRCULATING TUMOR CELL; COLON CANCER; FEMALE; FILTRATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MELANOMA; PROSTATE CANCER; TELOMERE; THREE DIMENSIONAL IMAGING;

EID: 84874727652     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.12361     Document Type: Article

References (36)

1. Beitsch PD and Clifford E (2000). Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg 180, 446-449.
2. Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, et al. (2002). Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8, 2073-2084.
3. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, et al. (2007). Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 13, 4105.
4. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, et al. (2010). Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 25, 25ra23.
5. -7. Proc Natl Acad Sci USA 92, 537-541.
6. Desitter I, Guerrouahen BS, Benali-Furet N, Wechsler J, Jänne PA, Kuang Y, Yanagita M, Wang L, Berkowitz JA, Distel RJ, et al. (2011). A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res 31, 427-441.
7. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, and Riethmüller G (2002). Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360, 683-689.
8. Danila DC, Fleisher M, and Scher HI (2011). Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res 17, 3903-3912.
9. n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85, 6622-6626.
10. Blackburn EH (2000). The end of the (DNA) line. Nat Struct Biol 7, 847-850.
11. DePinho RA and Polyak K (2004). Cancer chromosomes in crisis. Nat Genet 36, 932-934.
12. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B, van den Doel R, Mougey V, Perrin M, Braun M, et al. (2004). The threedimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2, 12.
13. De Vos WH, Hoebe RA, Joss GH, Haffmans W, Baatout S, Van Oostveldt P, and Manders EM (2009). Controlled light exposure microscopy reveals dynamic telomere microterritories throughout the cell cycle. Cytometry A 75A, 428-439.
14. Mai S and Garini Y (2005). Oncogenic remodeling of the three-dimensional organization of the interphase nucleus: c-Myc induces telomeric aggregates whose formation precedes chromosomal rearrangements. Cell Cycle 4, 1327-1331.
15. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z, Kuttler F, Chuang TC, Moshir S, Mougey V, et al. (2005). c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102, 9613-9618.
16. Saito T, Hama S, Izumi H, Yamasaki F, Kajiwara Y, Matsuura S, Morishima K, Hidaka T, Shrestha P, Sugiyama K, et al. (2008). Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells. Br J Cancer 98, 345-355.
17. Mai S and Garini Y (2006). The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97, 904-915.
18. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, and De Marzo AM (2004). Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10, 3317-3326.
19. Guijon FB, Greulich-Bode K, Paraskevas M, Baker P, and Mai S (2007). Premalignant cervical lesions are characterized by dihydrofolate reductase gene amplification and c-Myc overexpression: possible biomarkers. J Low Genit Tract Dis 11, 265-272.
20. Knecht H, Sawan B, Lichtensztejn D, Lemieux B, Wellinger RJ, and Mai S (2009). The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells. Leukemia 23, 565-573.
21. Gadji M, Fortin D, Tsanaclis AM, Garini Y, Katzir N, Wienburg Y, Yan J, Klewes L, Klonisch T, Drouin R, et al. (2010). Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia 12, 183-191.
22. Gadji M, Awe JA, Rodriguez P, Klewes L, Kumar R, Houston DS, Falcao RP, de Oliveira FM, and Mai S (2012). Three-dimensional nuclear telomeric architecture defines cytopenias of myelodysplastic syndrome and its transformation to acute myeloid leukemia. Clin Cancer Res 18, 3293.
23. Vermolen BJ, Garini Y, Mai S, Mougey V, Fest T, Chuang TC, Chuang AY, Wark L, and Young IT (2005). Characterizing the three-dimensional organization of telomeres. Cytometry A 67, 144-150.
24. Knecht H and Mai S (2011). 3D imaging of telomeres and nuclear architecture: an emerging tool of 3D nano-morphology-based diagnosis. J Cell Physiol 226, 859-867.
25. Schaefer LH, Schuster D, and Herz H (2001). Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy. J Microsc 204, 99-107.
26. Molnar B, Floro L, Sipos F, Toth B, Sreter L, and Tulassay Z (2001). Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 7, 4080.
27. Glaves D (1984). Correlation between circulating tumor cancer cells and incidence of metastases. Br J Cancer 50, 159-166.
28. Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ, and Tai YC (2007). Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 1162, 154-161.
29. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LWMM, et al. (2006). Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 12, 6403.
30. Weinberg RA (2006). The Biology of Cancer. Garland Science, New York, NY.
31. - objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 21, 1851-1857.
32. Schwarzenbach H, Hoon DS, and Pantel K (2011). Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11, 426-437.
33. Pelkey T, Frierson HJ, and Bruns D (1996). Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42, 1369-1381.
34. Louha M, Nicolet J, Zylberberg H, Sabile A, Vons C, Vona G, Poussin K, Tournebize M, Capron F, Pol S, et al. (1999). Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 29, 879-882.
35. Cama C, Olsson C, Buttyan R, De Vries G, Wise G, and Katz A (1997). Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J Urol 157, 1748-1751.
36. Kane RD, Hawkins HK, Miller JA, and Noce PS (1975). Microscopic pulmonary tumor emboli associated with dyspnea. Cancer 36, 1473-1482.